BELLUS Health Inc. (BLU)

4.42
0.00(0.00%)
  • Volume:
    65,007
  • Bid/Ask:
    4.42/4.43
  • Day's Range:
    4.24 - 4.47

BLU Overview

Prev. Close
4.42
Day's Range
4.24 - 4.47
Revenue
-
Open
4.35
52 wk Range
2.7 - 16.67
EPS
-0.66
Volume
65,007
Market Cap
346.25M
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
169,709
P/E Ratio
-
Beta
-0.58
1-Year Change
-69.52%
Shares Outstanding
78,337,361
Next Earnings Date
May 10, 2021
What is your sentiment on BELLUS Health Inc.?
or
Market is currently closed. Voting is open during market hours.

BELLUS Health Inc. News

BELLUS Health Inc. Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellStrong Sell
SummaryNeutralNeutralStrong SellStrong SellStrong Sell

BELLUS Health Inc. Company Profile

BELLUS Health Inc. Company Profile

Sector
Services
Employees
32
Market
Canada

BELLUS Health Inc is a Canada-based biopharmaceutical development company. The Company's pipeline of projects includes the BLU-5937 for chronic cough and several other partnered clinical-stage drug development programs. BLU-5937 is a potent, selective, orally bio-available small molecule antagonist of the P2X3 receptor, a clinically validated target for chronic cough. BLU-5937 has the potential to help a number of chronic cough patients who do not respond to current therapies. BELLUS Health Inc also has economic interests in other partnered clinical-stage drug development programs, including KIACTA for sarcoidosis, AMO-01 for Fragile X Syndrome and ALZ-801 for APOE4 homozygous Alzheimer’s disease.

Read More
  • 5+
    0
    • https://finance.yahoo.com/news/trade-alert-chairman-board-bellus-100118377.html
      1
      • G
        0
      • Still going down am I missing somethingg guys?
        0
      • O thought this one would go UP.
        0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.